SBC Medical Q1 revenue down 14% to $47M; net income up 15%; $5M buyback

SBC Medical Group Holdings Inc

2025-Q1 EPS reported $0.21 revenue$47,328,701

Revenue $47M (-14% YoY); operating income $24M (-1%); net income $22M (+15%); EPS $0.21 (+5%).
EBITDA $25M (-3%); margin improved to 52% from 46%. Partner clinics 251; customers 6.1M (+14%).
Board approves $5M share repurchase program (May 20, 2025 – May 20, 2026); defers JPY 1B Bitcoin purchase plan.
Begins review of acquiring Risenet (management-support services) from CEO; price and timing not yet determined.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.